NUBEQA

Bayer Inc🇨🇦 Health Canada

Approval Id: 87ec3bc71f79521f
Drug Approval Canada Name: NUBEQA
Product Name: NUBEQA
Status: Marketed
Status Date: 2020-03-24
Original Market Date: 2020-03-24
Din: 02496348
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L02BB06 DAROLUTAMIDE
Atc Name: l 02 bb 06
Aig Number: 0162034001
Company Name: Bayer Inc
Company Address: 2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6

DAROLUTAMIDE

300 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

87ec3bc71f79521f

Type

Standard